Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis
This HEDIS Measure
Assesses adults diagnosed with rheumatoid arthritis (RA) who were dispensed at least one ambulatory prescription for a disease-modifying anti-rheumatic drug (DMARD).
RA is a chronic inflammatory disease in which the immune system attacks healthy joints.1 It causes inflammation and destruction of joints and can also damage organs.2 RA is progressive, but early intervention with DMARDs can help preserve function and prevent further damage to joints.2
- Centers for Disease Control and Prevention. 2012. “Rheumatoid Arthritis.” http://www.cdc.gov/arthritis/basics/rheumatoid.htm
- American College of Rheumatology. 2012. “Rheumatoid Arthritis.” http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/ra.asp